Novel Anti-CD40 Monoclonal Antibody CFZ533 in Patients with Primary Sjogren Syndrome: A Phase Iia Double-Blind, Placebo–Controlled Randomized Trial

Publication date: October 2018

Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Volume 126, Issue 4

Author(s): Arwa Farag, Athena Papas, Benjamin Fisher, Margit Zeher, Wan-Fai Ng, Michele Bombardieri, Maximilian Posch, Thomas Daikeler, Bettina Bannert, Alan Kivitz, Steven Carsons, David Isenberg, Francesca Barone, Simon Bowman, Pascal Espie, Grazyna Wieczorek, Pierre Moulin, David Floch, Cyrielle Dupuy, Xiaohui Ren

https://ift.tt/2PlZEWi